Novartis5h
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
The American Journal of Managed Care17h
Dr Toon Van Gorp: Mirvetuximab Soravtansine Should Be Global Standard for FRα+ Ovarian Cancer
Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...
Scientists discover new inhibitors of inflammation-related enzyme
Using computational tools and virtual screening, researchers at the Center for Redox Processes in Biomedicine (Redoxoma) have ...
Endocrinology Advisor1d
GLP-1 Drugs Associated With a Reduced Risk of Multiple Age-Related Ocular Diseases
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
globalseafoods14d
Wild Alaskan Silver Salmon Lox 101: A Complete Guide to This Delicacy Excerpt:
Salmon lox, often referred to simply as "lox," is a salt-cured salmon delicacy enjoyed worldwide for its silky texture and rich flavor. Unlike smoked salmon, which undergoes both curing and smoking, ...
Medical News Today21d
Best CBD for Anxiety in 2025: Top Gummies, Oils, and More
Keep in mind that as a full-spectrum product, these contain 1.5 milligrams (mg ... have the issue of waking up once or twice around 2 or 3 a.m. So, I’d say these are great for helping you ...
Too Old to Operate24d
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
MONDAY, Feb. 24, 2025 (HealthDay News) — For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs ... found that the rate difference of depression was 3 ...
FoodNavigator24d
Is this GLP-1.2? New generation of weight-loss drugs moving in
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With the potential to significantly change consumer eating habits, they are ...
Medical Xpress25d
Study finds GLP-1 receptor agonists target fat over muscle for weight loss
Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have shown significant effectiveness in both lowering blood sugar ...
Science Daily25d
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have shown significant effectiveness in both lowering blood sugar ...
Science Daily25d
Immune 'fingerprints' aid diagnosis of complex diseases
T and B cells together The researchers found that T cell receptor sequences provided the most relevant information about lupus and Type 1 diabetes while B cell receptor sequences were most ...